Ocular Therapeutix (OCUL) Other Non-Current Liabilities (2013 - 2026)

Ocular Therapeutix has reported Other Non-Current Liabilities for 11 years, with the latest figure at $909000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 531.25% year-over-year to $909000.0; the trailing twelve-month figure through Mar 2026 stood at $909000.0 (up 531.25% YoY), and the FY2025 full-year result was $13.9 million, up 9760.28% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $909000.0, down from $13.9 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $30.0 million in Q4 2023, with the low at $117000.0 in Q3 2024.
• Average Other Non-Current Liabilities over 5 years is $10.6 million, with a median of $11.6 million recorded in 2022.
• Year-over-year, Other Non-Current Liabilities plunged 99.53% in 2024 and jumped 12688.03% in 2025.
• Tracing OCUL's Other Non-Current Liabilities over 5 years: stood at $6.4 million in 2022, then surged by 372.16% to $30.0 million in 2023, then sank by 99.53% to $141000.0 in 2024, then jumped by 9760.28% to $13.9 million in 2025, then slumped by 93.46% to $909000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $909000.0 (Q1 2026), $13.9 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.

Peer Comparison